Search

Learn about the clinical trials and research at MSK that led to FDA approvals in 2025, expanding treatment options for a range of different cancers.

… Monday, December 15, 2025 The U.S. Food and Drug Administration (FDA) approved 10 cancer drugs in 2025, based on clinical trials in which MSK played a pivotal role.  These approvals spanned therapies for a range of solid tumors and blood cancers and included treatments for both common and rare types 

Memorial Sloan Kettering Cancer Center (MSK) was recently notified of a data security incident by Blackbaud, a third-party vendor and provider of fundraising software used by MSK’s Office of Development. This incident at Blackbaud affected hundreds of nonprofits and higher education institutions around the world, including MSK.

… Monday, September 14, 2020 Memorial Sloan Kettering Cancer Center (MSK) was recently notified of a data security incident by Blackbaud, a third-party vendor and provider of fundraising software used by MSK’s Office of Development. This incident at Blackbaud affected hundreds of nonprofits and higher

Learn about Dana and the uterine transposition surgery at MSK in NYC, that enabled her to give birth to a baby named Hudson, who made history.

… Tuesday, September 3, 2024 When Dana Vergara cradles her sweet baby, Hudson, she can hardly believe it.  Dana was 33 years old and the mother of a 5-month-old daughter, Jolene, when she learned that she had  stage 3 rectal cancer . She knew it was bad. She wasted no time reaching out to specialists at

Conozca a Dana y la cirugía de transposición uterina en MSK en la ciudad de Nueva York, que le permitió dar a luz a un bebé llamado Hudson, que hizo historia.

… Tuesday, September 3, 2024 Cuando Dana Vergara acuna a su dulce bebé, Hudson, apenas puede creerlo.  Dana tenía 33 años y era madre de una hija de 5 meses, Jolene, cuando se enteró de que tenía cáncer de recto en estadio 3 . Sabía que era malo. No demoró en ponerse en contacto con los especialistas del

Learn everything you need to know about donating bone marrow or blood stem cells and why it’s important to join a public registry.

… Thursday, July 25, 2024 Imagine finding out that your bone marrow or blood stem cells could save the life of someone who needed it — even a complete stranger. Memorial Sloan Kettering Cancer Center (MSK) nurse Grace Yang, RN, received such a call in March 2024.   “This is definitely something I was never

Using patients’ own immune systems to fight cancer has been one of the most exciting advances in cancer treatment over the past decade. Now, a new immunotherapy could take this approach to the next level.

… Thursday, July 1, 2021 Using patients’ own immune systems to fight cancer has been one of the most exciting advances in cancer treatment over the past decade. Now, a new immunotherapy could take this approach to the next level. The treatment, called tumor infiltrating lymphocyte (TIL) therapy, harnesses

The incidence of colorectal cancer in those under the age of 50 has been increasing globally at an alarming rate. Pinpointing the reason remains elusive. Memorial Sloan Kettering has just opened the first center in the world dedicated to research and treatment of the disease as it presents in this demographic.

… Thursday, March 15, 2018 We are excited to announce the opening of the Center for Young Onset Colorectal Cancer at Memorial Sloan Kettering Cancer Center. This is the first center in the world dedicated to adults under the age of 50 with colorectal cancer. Its two-part mission is to: provide coordinated

MSK researchers recently reported results of a phase 2 trial for GIST, a rare form of gastrointestinal cancer. The trial was based on years of lab work conducted by physician-scientist Ping Chi.

… Friday, February 11, 2022 When Luis Portiansky had his first surgery in 1993 for a rare form of cancer that developed in his stomach, Ping Chi was still an undergraduate student at Mount Holyoke College in Massachusetts. More than two decades later, when Luis’ cancer came back for the third time, Dr.

Patients with inoperable advanced liver cancer have a new option for treatment to extend their lives.

… Monday, October 24, 2022 Patients with inoperable advanced liver cancer have a new option for treatment to extend their lives. Today the U.S. Food and Drug Administration (FDA) approved a combination of the immunotherapy drugs durvalumab (Imfinzi®) plus the experimental drug tremelimumab for people with

Fellowship recipient Dr. Francisco Sanchez-Vega will research factors that lead to negative colorectal cancer outcomes in Black communities.

… Thursday, April 13, 2023 Corning Incorporated and Memorial Sloan Kettering Cancer Center (MSK) announced today that Dr. Francisco Sanchez-Vega, PhD, has been awarded the Corning-MSK Health Equity Research Fellowship, a two-year grant that funds research into the broad disparities in cancer outcomes for